LAVA Therapeutics (LVTX)
NASDAQ:LVTX
US Market

LAVA Therapeutics (LVTX) Income Statement

Compare
161 Followers

LAVA Therapeutics Income Statement

Last quarter (Q3 2024), LAVA Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, LAVA Therapeutics's net income was $-12.30M. See LAVA Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 11.98M$ 6.77M$ 19.39M$ 5.35M$ 3.75M
Gross Profit
$ 11.98M$ 3.29M$ 19.39M$ 5.35M$ -11.95M
Operating Expenses
$ 41.67M$ 46.54M$ 51.31M$ 46.92M$ 3.59M
Depreciation and Amortization
$ 0.00$ 1.28M$ 504.00K$ 331.00K$ 213.00K
EBITDA
$ 0.00$ -40.42M$ -30.88M$ -41.02M$ -14.65M
Operating Income
$ -29.69M$ -43.25M$ -34.84M$ -43.61M$ -14.67M
Other Income/Expenses
$ 3.95M$ 1.56M$ 3.18M$ 1.42M$ -1.21M
Pretax Income
$ -25.74M$ -41.70M$ -31.66M$ -42.20M$ -15.88M
Net Income
$ -25.11M$ -41.97M$ -31.91M$ -42.35M$ -15.93M
Per Share Metrics
Basic EPS
$ -0.94$ -1.57$ -1.23$ -2.14$ -39.90
Diluted EPS
$ -0.94$ -1.57$ -1.23$ -2.14$ -39.90
Weighted Average Shares Outstanding
26.83M 26.73M 25.92M 19.76M 25.35M
Weighted Average Shares Outstanding (Diluted)
26.83M 26.73M 25.92M 19.76M 25.35M
Currency in USD

LAVA Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis